INTRODUCTION
The relationship between chronic inflammation and human diseases such as cancer has moved from association to essentially cause and effect 1, 2 , although efforts to predict the risk of diseases associated with inflammation have lagged due to weaknesses in our ability to quantify the chemical and molecular events that link inflammation with disease. The strongest link entails a scenario in which local infection, tissue damage or autoimmune dysfunction signals the infiltration and activation of macrophages and neutrophils to eradicate the offending stimuli 3 . Activation of the phagocytes causes them to secrete a host of bioactive molecules, such as nitric oxide (NO) and superoxide (O 2 À ) by macrophages and hypochlorous acid (HOCl) by neutrophils ( Fig. 1 4) . These reactive oxygen and nitrogen species attack virtually all types of cellular molecules to produce mutation and cell death, which ultimately lead to expression of disease. Given the potential for DNA damage to play a causative role in mutation and carcinogenesis, we have developed a highly sensitive method to quantify DNA damage products as biomarkers of inflammation.
Of a general three-step approach to the development of biomarkers 5 , the first step involves selection of an appropriate target molecule(s) thought to be involved in the pathogenic mechanism, which poses a challenge given limited knowledge of the chemistries actually occurring at sites of inflammation. DNA is thus considered to be a major mechanistic target in the association of chronic inflammation with diseases such as cancer, such that DNA damage products may represent biomarkers of inflammation in the carcinogenic process 4, 6, 7 . As shown in Figure 2 , the major outcomes of damage to DNA by chemical mediators of inflammation are predicted to fall into three categories: nitrosation, nitration/ oxidation and alkylation. The major source of nitrosative deamination of DNA bases is N 2 O 3 , which is derived from the interaction of NO and O 2 and causes conversion of cytosine to uracil (2¢-deoxyuridine, dU), guanine to xanthine or oxanine (2¢-deoxyxanthosine, dX, or 2¢-deoxyoxanosine, dO, respectively) and adenine to hypoxanthine (2¢-deoxyinosine, dI) 8, 9 . DNA is also subject to oxidative and nitrative assaults mainly as a consequence of ONOOCO 2 À that preferentially reacts with dG to form a variety of primary and secondary oxidation and nitration products 10, 11 . One of the major G oxidation products, 8-oxo-2¢-deoxyguanosine (8-oxodG) , is approximately 1,000-times more reactive than dG toward further oxidation to yield a host of more stable secondary oxidation products 12 . It is thus critical to control oxidation artifacts during sample preparation and analysis to determine the correct cellular concentration of 8-oxodG. The third category of DNA lesions arises from reactions of DNA with electrophilic products derived from oxidation of other cellular molecules, such as reactions of lipid peroxidation-derived a,b-unsaturated aldehydes with DNA bases to form unsubstituted etheno adducts 1,N 2 -etheno-2¢-deoxyguanosine (1,N 2 -edG), N 2 ,3-etheno-2¢-deoxyguanosine (N 2 ,3-edG), 1,N 6 -etheno-2¢-deoxyadenosine (edA) and 3,N 4 -etheno-2¢-deoxycytidine (edC) 13, 14 , as shown in Figure 2 . The pyrimidopyrinone alkylation species, M 1 dG, can arise from reactions of DNA with both the base propenal product of 2-deoxyribose oxidation in DNA 15, 16 and malondialdehyde, a product of lipid peroxidation 17 . This wide spectrum of candidate chemistries and products arising from inflammation may pose a problem for selection of biomarker target molecules. To this end, we were motivated to develop a sensitive, robust and general approach to quantify DNA lesions caused by the known classes of inflammation chemistry shown in Figure 2 . It should be noted that there are many different products of DNA oxidation and alkylation arising from exposure to ionizing radiation and other insults [18] [19] [20] [21] [22] [23] [24] , but these species are unlikely to form under the biological conditions of inflammation 4 . Further, we have recently initiated efforts to include the cytosine and guanine halo-adducts arising from reactions of DNA with neutrophil-derived HOCl.
Analysis of low levels of DNA adducts in inflamed tissues is a challenging task that requires high specificity and sensitivity for unequivocal identification and quantification. The most widely used methods include immunoassays, 32 P and fluorescent post-labeling methods and methods coupling chromatography with mass spectrometry, each of which has advantages and disadvantages 25 . For example, the relative simplicity of immunoassays facilitates implementation of biomarkers in a clinical setting 26 , whereas post-labeling methods are considered among the most sensitive for the detection of very low levels of DNA adducts 27 . However, both methods suffer from a lack of chemical specificity and a lack of internal standards to control for loss and artifacts in sample preparation.
Alternatively, the MS-based methods provide unequivocal identification and the most rigorous quantification by employing isotopically labeled internal standards 28 . Gas chromatography coupled with mass spectrometry has proven to be a highly sensitive approach for the quantification of many types of DNA lesions, although the approach is not as readily applicable to nucleoside forms of base damage as liquid chromatography-based methods, and there is some controversy regarding artifacts associated with the method 29, 30 . Coupling reversed-phase HPLC with LC/MS-MS provides excellent separation of nucleosides, readily derived from DNA by enzymatic means, with highly sensitive quantification of 2¢-deoxynucleoside species by virtue of the characteristic loss of the deoxyribose moiety during collision-induced dissociation 31 . This combination of specificity and sensitivity with ease is unmatched by other bioanalytical methods. The major drawbacks to the use of tandem mass spectrometry are the high cost of the instruments, a requirement for relatively large amounts of DNA (10-100 mg) and the relatively low throughput of the analyses. A logical scenario that respects both the strengths and the drawbacks of MS-based analytical methods is to make an initial investment in developing DNA damage biomarkers of inflammation in animal models and limited human studies using LC/MS-MS technology, followed by the development of monoclonal antibodies against those biomarkers found to correlate with inflammation for application in widespread clinical use. To demonstrate the flexibility of our analytical method, we describe the application of the method using two different triple quadrupole mass spectrometry systems commonly available on university campuses with chemistry and bioscience departments and in academic medical centers.
A critical facet of any bioanalytical method for a rare biomolecule involves minimizing background noise or interfering signals for more abundant undamaged molecules. For example, the deaminated nucleobase products dX, dO, dI and dU are one mass unit larger than the canonical nucleobases from which they are derived (dG, dA and dC), such that isotope natural abundance could create an M + 1 signal for the highly abundant canonical nucleoside that could interfere with detection of the higher molecular weight deamination product. The addition of a prepurification step reduces the potential for these problems and increases the sensitivity of the assay. We have chosen to prepurify damaged nucleosides by HPLC. Prepurification can also be achieved by immunoaffinity purification, but the availability of antibodies is limiting, with HPLC offering the advantage of purifying a battery of DNA lesions simultaneously. After prepurification, the analytes are subject to a second, different chromatographic step in LC/MS-MS that further reduces interference. For example, the molecular weight of edC is identical to that of dA such that even a slight contamination with dA in the first HPLC resolution could overwhelm the billion-fold lower edC signal entirely. Even with an online immunoaffinity chromatography purification step, the problem of residual dA in the analysis of edC caused Roberts et al. 32 to convert dA to dI using adenosine deaminase. We have taken the more general approach of using a second and different chromatographic resolution step in which we are able to shift the retention time of edC before that of dA, making it possible for it to be quantified without interference from tailing of the dA peak.
A second challenge to the problem of the sensitivity and specificity of a method is the adventitious formation of DNA damage products during DNA isolation and processing steps. We have observed adventitious formation of dI and dU during DNA isolation and hydrolysis as a result of endogenous nucleobase deaminases and deaminase activities contaminating commercial enzyme preparations 9, 33 . This problem was completely controlled by adding the dA and dC deaminase inhibitors coformycin and tetrahydrouridine, respectively, to all buffers used during DNA isolation and processing. Oxidative artifacts, such as adventitious oxidation of dG to form 8-oxodG, is a major problem that has been shown to depend more on the operator and less on the method 34 and can be minimized by addition of the metal-chelating deferoxamine and the antioxidant butylated hydroxytoluene during DNA isolation and hydrolysis steps.
With all of these considerations, we describe a rigorous LC/ MS-MS method (Fig. 3) to quantify, in a single DNA sample, seven DNA damage products that reflect the spectrum of different chemistries associated with chronic inflammation 35 . The method yields results in accord with reliable published analyses of individual lesions in animal tissues 36, 37 .
Experimental design
There are several critical issues to consider before embarking on the quantification of damage products in cells or animal tissues. The first aspect of experimental design involves the choice of animal model and target tissue for analysis, with the requirement for inflammation studies of an inflammation-inducing stimulus, such as an infection, a noninflamed control group and, if at all possible, some evidence for pathology in the target organ. The studies should be designed to provide three or more animals per treatment group, which accommodates statistical treatments of the resulting biomarker quantification (e.g., Student's t-test). As the largest source of variance in the resulting biomarker levels lies in the individual tissue samples, it is recommended to design the experiment with more than three animals per treatment group. Tissues available in limiting amounts, such as the spleen in mice, may need to be pooled from several mice to provide a single analytical sample, which increases the number of mice per treatment group needed to provide a total of three independent analyses. Tissues from euthanized animals should be snap-frozen in liquid nitrogen as soon as possible after isolation and the DNA isolated immediately upon thawing the tissue. Although the protocol is written for tissue samples, the method is readily adapted to studies in cultured cells by simply designing the experiment with large enough cell cultures to provide 100 mg of DNA.
Another important issue to consider in the experimental design is the availability of instruments. We demonstrate the method with two mass spectrometer systems that provide slightly different sensitivities for the various DNA damage products. Although the method can be applied to any triple-quadrupole instrument with minor adjustments of the mass spectrometer parameters, the parameters must be determined in experiments first with unlabeled standards and then with samples consisting of purified DNA spiked with labeled and unlabeled internal standards to account for contaminants in the enzyme and buffer preparations and other sources unique to the local environment.
The overall method is outlined in Figure 3 .
MATERIALS

REAGENTS
. 5181-1270) m CRITICAL Glass inserts must be used for trace level analysis to prevent contamination coming from the less expensive polypropylene inserts.
. Vortexer (e.g., VWR Vortex Genie) . SpeedVac (Savant)
REAGENT SETUP General comments on the synthesis of Internal Standards Syntheses should always be attempted first with unlabeled material to check the procedure and optimize the reaction conditions before starting syntheses with more expensive isotopically labeled reagents. Always verify the structures of synthesized standards by mass spectrometry, UV/visible spectroscopy and NMR spectroscopy, depending on the availability of these instruments. The yield for each of the following syntheses is expected to be at least 70% overall, but will vary depending upon experience and other factors. ]-2¢-deoxyadenosine (0.05 mmol) in 3 ml of 100 mM potassium phosphate buffer (pH 6) and then add 40 ml of 50% chloroacetaldehyde (0.26 mmol) and stir at ambient temperature for 24 h followed by 2 h at 37 1C; both incubations should be performed in the dark (wrap the reaction vessel in aluminum foil). Product is purified by HPLC as described above with elution time verified using commercially available edA and the product characterized by UV-visible spectroscopy and mass spectrometry. Quantification of the standard is performed by UV spectroscopy using an extinction coefficient of 10,300 M À1 cm À1 at 260 nm (refs. 42,43) . at 37 1C for 6 h. dX and dO are purified by HPLC using a LUNA C18 reversed-phase column (250 mm Â 3 mm, 5 mm particle size, 100 Å pore size; Phenomenex) with elution performed at a flow rate of 0.4 ml min À1 with 1% acetonitrile in 50 mM ammonium acetate (pH 7.4) for the first 5 min, followed by a linear gradient of 1-25% acetonitrile for 5 min; holding at 25% for 10 min; then a reversal of the gradient to 1% for 5 min; and finally eluting at 1% acetonitrile over the last 5 min. Fractions containing the products are dried under vacuum and redissolved in water followed by desalting on a second HPLC system consisting of a Haisil HL C18 reversedphase column (250 mm Â 4.6 mm, 5-mm particle size, 100 Å pore size; Higgins Analytic Inc.) eluted with 5% acetonitrile in water at a flow rate of 0.4 ml min À1 , with elution confirmed using commercially available standards. Quantification of the standards is performed by UV spectroscopy using the following extinction coefficients: dX, 2¢-Deoxyinosine (dI) and 2¢-deoxyuridine (dU) There are two approaches for the synthesis of 15 N-labeled and unlabeled dI and dU. One exploits the presence of dA and dC deaminase activities in commercial preparations of alkaline and acid phosphatases, respectively 9 . dA and dC are incubated with 0.5 U of alkaline phosphatase (Sigma Chemical Co.) and acid phosphatase (Roche), respectively, per mg of nucleoside in supplied buffers at 37 1C for 3 h followed by removal of enzymes by filtration on a Microcon YM-30 column (Millipore Corporation). Alternatively and more reliably, dI and dU are prepared by reacting 10 mM dA or dC with 100 mM NaNO 2 in 0.3 M sodium acetate buffer (pH 3.7) at 37 1C for 6 h. Using either approach, the products are purified by HPLC using a HAISIL HL C18 reversed-phase semipreparative column (250 mm Â 10 mm, 5-mm particle size, 100 Å pore size) eluted with 5% acetonitrile in water at a flow rate of 4 ml min À1 , with elution confirmed using commercially available standards. Products are characterized by UV-visible spectroscopy and MS. Quantification of the standards is performed by UV spectroscopy using the following extinction coefficients: dI, 12,800 M À1 cm À1 at 249 nm; dU, 10,100 M À1 cm À1 at 262 nm (ref. 46) . m CRITICAL To avoid contamination of the labeled and unlabeled internal standards (and ensuing loss of isotopic purity), either purify the two species on separate HPLC systems (separate columns will not suffice, as most carryover contamination involves the injector port and sample loop) or wash the HPLC column and the injection port/sample loop by performing multiple injections with a series of solvents of different polarity (e.g., acetonitrile, 50% methanol in water, pure water). The isotopic purity is best assured by purchasing labeled materials with high isotope content (498%) and will be apparent during mass spectrometric analysis of the product.
PROCEDURE
Tissue harvesting 1| Following euthanasia by CO 2 asphyxiation, necropsy is performed using sterile instruments. m CRITICAL STEP All experiments employing vertebrate animals must be approved by an appropriate institutional committee on animal care and employ the most humane procedures possible.
2|
The organs of interest are promptly chopped into 100-200 mg pieces, with each piece placed in a polypropylene microcentrifuge tube and immediately flash-frozen in liquid nitrogen. Note: The amount of tissue needed from a specific organ will vary since the yield of DNA differs for each organs. Table 1 lists the suggested amounts of various mouse tissues that will yield at least 100 mg of DNA, the amount needed for the analysis of the DNA damage products.
DNA extraction (DNA isolation kit for cells and tissues) 3|
Transfer the previously snap-frozen tissue into a 50-ml conical polypropylene tube (Falcon) filled with 5 ml of lysis buffer (included with kit) containing all appropriate inhibitors and antioxidants to minimize adventitious damage (e.g., 5 mg ml À1 coformycin, 50 mg ml À1 tetrahydrouridine, 100 mM deferoxamine, 100 mM butylated hydroxytoluene). m CRITICAL STEP The addition of appropriate deaminase inhibitors and antioxidants minimizes artifacts arising during sample workup, which could lead to an overestimation of adduct levels.
4| Process the tissue sample using a mechanical homogenizer (Fisher PowerGen 1800 model) at half-maximal speed for at least 10 s.
5| Transfer the homogenized sample to a 15-ml conical polypropylene tube (Falcon) for easier sample manipulation.
6| Add 3 ml of proteinase K solution (included in kit), vortex for 5 s to mix and incubate at 65 1C for 1 h in a water bath or temperature-controlled heating block.
7|
Remove from heat source, loosen the cap to vent and cool the tube to 37 1C.
8| Add 400 ml of RNase solution (included with kit), vortex for 5 s to mix and incubate at 37 1C for 1 h. m CRITICAL STEP The amount of RNase used and the incubation time are longer than specified by the kit manufacturer. This ensures complete digestion of the RNA to avoid interference with the UV quantification of total DNA before analysis.
9| Add 2.1 ml of protein precipitation solution (included with kit) containing 5 mg ml À1 coformycin, 50 mg ml À1 tetrahydrouridine, 100 mM deferoxamine and 100 mM butylated hydroxytoluene and vortex the sample thoroughly for 10 s.
10| Cool the sample on ice for 5 min. 12| Following centrifugation, carefully transfer the supernatant into a new 15-ml conical polypropylene tube (Falcon) and add 0.7 volumes of isopropanol to each sample.
13| Invert the tubes gently to mix and precipitate the DNA.
14| There are two options for recovering the DNA depending upon the DNA yield. Perform the steps in option A for low DNA yields and those in option B for high DNA yields. 15| Dry the pellet in a fume hood for 420 min to evaporate all of the ethanol.
16| Dissolve the DNA in 1 ml of sterile (autoclaved) deionized water. m CRITICAL STEP The DNA must be completely dissolved in the water before proceeding and complete dissolution of quantities of DNA greater than 100 mg may require several hours of incubation (best results with overnight incubation) at ambient temperature (or 37 1C) with shaking.
17| Measure the DNA concentration by absorbance at 260 and 320 nm. The absorbance at 260 nm should be corrected by subtracting absorbance at 320 nm. Using a 1-cm path length, 1 absorbance unit at 260 nm (A 260 unit) ¼ 50 mg ml À1 double-stranded DNA. The measured DNA sample should be diluted as needed to maintain absorbance values at 260 nm within the linear range of most UV-visible spectrophotometers, which is generally between 0.1 and 1 absorbance units. ' PAUSE POINT The sample in the capped vial can be stored at À20 1C for at least 2 weeks and longer at the recommended temperature of À80 1C.
Hydrolysis of DNA to nucleotides and addition of isotopically labeled internal standards 18| Prepare samples containing 100 mg of DNA in 1.5-ml polypropylene microcentrifuge tubes. Note that this quantity of DNA is more than actually needed for quantification of many of the DNA lesions, but it ensures that all damage products will be present at levels exceeding the limits of quantification.
19| Dry the DNA completely under vacuum taking care to minimize drying time to avoid artifacts. m CRITICAL STEP Subjecting the DNA to prolonged drying time, heating or contamination during the drying step can create artifacts due to oxidation and other reactions. There are two approaches to avoid these problems. One is to empirically determine the minimal time needed to dry the sample in a particular solvent evaporation system. Alternatively, solvent removal can be stopped when a minimal (B2-3 ml) volume of water remains in the tube. In both cases, the solvent evaporation should be performed at ambient or a lower temperature in a very clean system. The effects of different drying methods can be assessed by comparing the levels of DNA damage products in samples subjected to different drying conditions. 20| Using the volumes specified in Table 2 , prepare a 'cocktail' containing all enzymes and cofactors needed for hydrolysis of the DNA into nucleosides as well as all inhibitors and antioxidants to minimize artifacts and appropriate internal standards for adduct measurement. Multiply the quantities of each reagent noted in Table 2 by the number of samples plus one additional sample to be used as a parallel control. Combine the reagent volumes and mix by vortexing. Note that the final pH of this solution is higher than the pH optimum for nuclease P1, which is intended to minimize depurination of 2¢-deoxyxanthosine (dX) under more acidic conditions, yet it still preserves nuclease P1 activity. Also, note that the amount of isotopically labeled internal standard added to each sample has been determined empirically to produce a reasonable signal intensity that correlates with both background and elevated levels of damage products expected for the amount of DNA used in each sample (see the ANTICIPATED RESULTS).
21| Add 55 ml of the 'cocktail' to each dried DNA sample and redissolve the DNA by vortexing; add 55 ml of the 'cocktail' to an empty microcentrifuge tube as a control to be processed in parallel. m CRITICAL STEP Given the inaccuracy associated with pipetting small volumes (r1 ml), the use of a stock solution divided among all of the samples minimizes pipetting errors that could ultimately affect quantification of the damage products.
22| Incubate the samples for 3 h at 37 1C.
Further DNA hydrolysis and dephosphorylation of nucleotides 23| Prepare a second 'cocktail' for another round of DNA hydrolysis and dephosphorylation to form nucleosides. Multiply the quantities of each stock reagent shown in Table 3 by the number of samples plus one additional sample to be used as a parallel control. Combine the reagent volumes and mix by vortexing. m CRITICAL STEP Addition of phosphodiesterase I at this step, along with the alkaline phosphatase ensures complete hydrolysis of the DNA sample to nucleosides.
24| Add 45 ml of the cocktail to each DNA sample and the control and incubate at 37 1C overnight. Note that the 'cocktails' prepared in Steps 20 and 23 have been optimized to keep sample volumes at the 100 ml maximal injection volume for an Agilent 1100 series HPLC autosampler. ! CAUTION The addition of deaminase inhibitors is critical here to inhibit adventitious formation of dI and dU.
Removal of enzymes 25| Rinse a 10,000 MW cut-off spin filter (Amicon) by adding 300 ml of deionized water and centrifuging for 45 min at 16,400g at 4 1C.
26|
Replace the collection tube containing rinse water with a fresh collection tube.
27|
Transfer the hydrolyzed DNA sample to the washed spin filter and centrifuge for 45 min at 16,400g at 4 1C.
HPLC prepurification of nucleosides 28| Transfer the filtrate from
Step 27 into a 100-ml insert tube (Agilent), place the insert in a 2-ml screw top vial (Agilent) and cap the vial. ' PAUSE POINT The sample in the capped vial can be stored at À20 1C for at least 2 weeks and longer at the recommended temperature of À80 1C.
29| Prepare the HPLC system by equilibrating the column temperature to 32 1C and equilibrating the Phenomenex Synergi 4-mm Hydro-RP C18 column 80A 250 mm Â 4.6 mm with 99% 8 mM ammonium acetate and 1% acetonitrile for at least 20 min at 0.500 ml min À1 .
30|
Test the column by injecting a 1-ml volume of standards containing the damaged nucleosides at a concentration of 10 mM and the normal nucleobases at a concentration of 100 mM and running the system through the elution cycle as described in Table 4 .
! CAUTION Injecting excessive amounts of standards will result in carryover of unlabeled material into the unknown samples, which will result in an overestimation of adduct levels during LC/MS-MS quantification. Inject enough amounts of each standard to produce only a minimally detectable UV absorbance. Check for carryover by injecting water and observing the LC/MS-MS signals, as described in the section starting at Step 36. m CRITICAL STEP Use this step to evaluate column performance before injecting DNA samples. 
Stock solution of reagent
Volume added (ll) 30 mM sodium acetate (pH 7.8) 40 2 mg ml À1 of coformycin in deionized water 1 17 U ml À1 of alkaline phosphatase in deionized water 2 100 U ml À1 of phosphodiesterase I in deionized water 2 Total volume 45 be performed before preparing DNA samples. If the column does not provide adequate resolution (e.g., 8-oxo-dG is not well resolved from dT), then try reversing the column orientation (i.e., the outlet becomes the inlet). If that does not solve the problem, then return the column to the manufacturer and get a replacement column from a different lot.
31| Inject 100 ml of water and run through the elution cycle to eliminate carryover of the standards.
32| Inject the hydrolyzed DNA samples (B100 ml) onto the HPLC system using the autosampler and elute the nucleosides by applying the gradient described in Table 4 .
33| Fractions of eluate containing the various nucleosides are collected on the basis of predetermined retention times, with the following example based on our experience-dX: start collecting at 13.0 min and stop when dC begins to elute; dU: 23.2-25.0 min; dI: 34.0-36.5 min; 8-oxo-dG: 48.2-50.7 min; 1,N 2 -edG: 63.7-65.8 min; edC and edA: 68.0-72.0 min. As shown in Figure 4 , edC and edA do not always separate well, so it may be necessary to collect a single fraction containing both species. edC and edA will separate from each other on the Thermo-Hypersil Gold column during LC/MS-MS analysis. m CRITICAL STEP Owing to the abundance of dA, the fraction containing edC and edA contain a large amount of dA, even though dA elutes 6-7 min earlier on the Phenomenex column. The presence of dA poses a problem for quantification of edC, as both edC and dA produce the same molecular ion (M+H) at m/z 252 and the same fragment ion [(M+1) À 116 (sugar)] at m/z 136 at the unit resolution at which the triple quadrupole mass spectrometer operates. A complete baseline HPLC separation of edC and dA is thus crucial. This is achieved in the LC/MS-MS step using a Thermo-Hypersil Gold column operated at a column temperature of 10 1C to provide complete baseline separation of edC, dA and edA.
34| Wash the collected fractions twice by drying under vacuum, redissolving in 300 ml of deionized water and drying under vacuum again. m CRITICAL STEP To minimize organic solvent reaching the vacuum pump, a cold trap set at À100 1C must be installed between the SpeedVac and pump.
35| Dissolve each dried sample in 45 ml of deionized water. m CRITICAL STEP It is important to wash the sample several times and dry completely after each wash to evaporate as much of the volatile ammonium acetate as possible. Like any salt, ammonium acetate has the potential to suppress ionization, and thus detection of the analyte during MS analysis, and to foul the ionization source. This is particularly important for systems that do not have a diverter valve to route the void volume of salts to waste, as the salts can accumulate in the ionization source over time. ' PAUSE POINT The sample can be stored at À20 1C for at least 2 weeks or longer at the recommended temperature of À80 1C.
Preparation of samples for calibration curves 36| Prepare samples to be used for calibration curves to convert mass spectrometer signals to meaningful concentrations of damaged nucleosides in the DNA samples. In individual microcentrifuge tubes in triplicate, add aliquots of stocks of individual unlabeled standards to yield concentrations noted in Table 5 to make a final volume of 45 ml. The concentrations of internal standards in the calibration curve samples should be identical to those used for the other DNA samples. The range of unlabeled nucleoside concentrations should encompass the expected values in background and treatment conditions.
Quantification of nucleosides by LC/MS-MS 37|
For each sample, inject 20 ml of the 45 ml sample volume onto the LC/MS-MS system, using conditions appropriate for each modified nucleoside (Tables 6 and 7) . The 20-ml portion of each sample will ensure a signal over the limit of quantification and for a duplicate analysis. m CRITICAL STEP First, analyses of the various DNA damage products must be performed separately to accommodate the different mass spectrometer parameters for each nucleoside (e.g., dI collected from all samples will be analyzed together). Individual calibration curve samples can be positioned at the end of each nucleoside analysis to avoid carryover contamination of the unknown samples. Second, the protocol describes analyses performed with two different triple quadrupole mass spectrometers to demonstrate the flexibility of the method. It can be readily adapted to any triple quadrupole system with minor adjustments due to machine-specific variations in sensitivity. Tables 6 and 7 , using a reversed-phase Thermo Hypersil Gold C18 column (150 mm Â 2.1 mm; 3-mm particle size) eluted at a flow rate of 200 ml min À1 using 0.1% acetic acid in deionized water (solvent A) and 0.1% acetic acid in HPLC-grade acetonitrile (solvent B) as mobile phases. To demonstrate the flexibility of the method, we describe the analysis of different adducts on two different triple quadrupole mass spectrometers. The two mass spectrometers provide different sensitivities for each adduct, so we have optimized parameters for two MS systems depending on which system provided the lowest limit of quantification for a nucleoside. For deamination damage products, perform the steps in option A, and for oxidative and etheno-adducts, perform the steps in option B.
38| Each nucleoside is analyzed by LC/MS-MS with slightly different HPLC and MS conditions, as noted in
(A) Deamination (dX, dI, dU) damage products (i) The HPLC column is coupled to an API 3000 tandem quadrupole MS with turbo ion spray.
(ii) MS is operated in positive ion mode with the first and third quadrupoles (Q1 and Q3, respectively) fixed to unit resolution.
(iii) The voltages and source gas are optimized for maximal sensitivity, and the parameters are as described in Table 6 . (B) Oxidative (8-oxo-dG) and etheno-adducts of dA, dC and dG (i) The HPLC is coupled to an Agilent 6410 triple quadrupole mass spectrometer with an ion spray ion source.
(ii) MS is operated in positive ion mode with the first quadrupole (Q1) fixed to wide resolution and the third quadrupole (Q3) fixed to unit resolution. (iii) The voltages and source gas are optimized for maximum sensitivity, and the parameters are as described in Table 7. 39| Using the software available with each system, obtain the peak area for each nucleoside and for its corresponding internal standard. 40| Calculate the peak area ratio for target nucleosides (unlabeled) and internal standards.
41|
Generate calibration curves by plotting the peak area ratios for the calibration curve samples as the independent variable against the concentration ratio of the unlabeled to labeled standards in the calibration curve samples. The calibration curves should be linear, typically with correlation coefficients, r 2 40.995.
42| Determine the concentration ratio for the unknown samples by interpolation from the linear calibration curves.
43| Calculate the amount of damaged nucleoside present in each sample by multiplying the concentration ratio by the concentration of labeled internal standard added during digestion. 
ANTICIPATED RESULTS
The baseline adduct levels for all of the damaged nucleosides are listed in Table 9 . Examples of the quantities of the DNA damage products observed in spleen, liver, and kidney from a mouse model of nitric oxide overproduction and inflammation can be found in Tables 1, 2 Include deferoxamine and butylated hydroxytoluene during cell processing, DNA extraction and hydrolysis steps; process samples on ice; minimize sample evaporation time As 8-oxo-dG can be formed from 2¢-deoxyguanosine (dG) in the ion source of the mass spectrometer, it is important that dG contamination separates well from 8-oxo-dG before entering the MS Decrease the % organic solvent to resolve dG from 8-oxo-dG edC levels are higher than expected Contamination of edC with dA due to similar HPLC retention times and identical m/z values Optimize the separation of edC and dA in the prepurification step. Also, optimize the HPLC step of the LC/MS-MS analysis to such that edC elutes 2-3 min before dA 
